Cervical cancer impacts over half a million women globally each year, with almost 90% of cases occurring in resource-limited settings. This is mainly due to the lack of population-based screening programs, which reduce the burden of disease in resource-replete settings through treatment of precancerous lesions. In sub-Saharan Africa, the cervical cancer disparity has worsened over the past twenty years due to the HIV epidemic, which increases the biologic risk for cervical cancer and has strained the already overburdened healthcare systems. In Uganda, the Ministry of Health has set an agenda for cervical cancer prevention over the next 5 years. It recognizes that in addition to employing evidence-based screening and treatment techniques, the overall population impact of cervical cancer screening depends on two main factors: (1) community-wide access to screening and (2) successful linkage to treatment or follow-up for women who screen positive. In Research Project 2, the Uganda-UCSF Consortium will evaluate a context-specific, community-based cervical cancer prevention program employing simple, low-cost screening and treatment techniques. Specifically, the program will provide cervical cancer screening with self-collected human papillomavirus (HPV) specimens offered through community health campaigns. The program will also provide cryotherapy through mobile treatment teams working in the local communities to reduce the risk of invasive cancer in women who test positive for HPV. Ongoing evaluation of the program will allow the research team to iteratively adapt the activities to address individual- and community-level factors.as well as processes that impact the uptake of screening and treatment.
The specific aims are to:
Aim 1 : Establish the acceptance and correlates of self-collected HPV-RNA testing among women in the rural Ugandan community as well as the incidence and determinants of successful completion of the cervical cancer screening cascade from self-collected IHPV testing to receipt of results Aim 2: Ascertain the frequency and determinants of successful acquisition of treatment among women who have HPV detected on self-collected swabs in rural Uganda.
Aim 3 : Derive population-based estimates of the prevalence of high-risk HPV and cervical intraepithelial neoplasia (CIN) detected through community-based screening employing self-collected HPV RNA testing in rural Uganda.

Public Health Relevance

Cervical cancer disproportionately impacts women in resource-limited settings, due to lack of screening programs. This research will address the context-specific factors necessary for the implementation of an effective screening and treatment program. It will have an immediate impact on women's health in Uganda by identifying and treating women at risk for cancer.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-RPRB-O (M2))
Program Officer
Dominguez, Geraldina
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California San Francisco
San Francisco
United States
Zip Code
Ayers, Leona W; Barbachano-Guerrero, Arturo; McAllister, Shane C et al. (2018) Mast Cell Activation and KSHV Infection in Kaposi Sarcoma. Clin Cancer Res 24:5085-5097
Semeere, Aggrey; Freeman, Esther; Wenger, Megan et al. (2017) Updating vital status by tracking in the community among patients with epidemic Kaposi sarcoma who are lost to follow-up in sub-Saharan Africa. BMC Cancer 17:611
Freeman, Esther; Semeere, Aggrey; Wenger, Megan et al. (2016) Pitfalls of practicing cancer epidemiology in resource-limited settings: the case of survival and loss to follow-up after a diagnosis of Kaposi's sarcoma in five countries across sub-Saharan Africa. BMC Cancer 16:65
Amerson, Erin; Woodruff, Carina Martin; Forrestel, Amy et al. (2016) Accuracy of Clinical Suspicion and Pathologic Diagnosis of Kaposi Sarcoma in East Africa. J Acquir Immune Defic Syndr 71:295-301
Semeere, Aggrey; Wenger, Megan; Busakhala, Naftali et al. (2016) A prospective ascertainment of cancer incidence in sub-Saharan Africa: The case of Kaposi sarcoma. Cancer Med 5:914-28
Nakalembe, Miriam; Mutyaba, Twaha; Mirembe, Florence (2016) Acceptability of study procedures (self-collected introital swabs, blood draws and stool sample collection) by students 10-16 years for an HPV vaccine effectiveness study: a pilot study. BMC Res Notes 9:170
Forrestel, A K; Naujokas, A; Martin, J N et al. (2015) Bacillary angiomatosis masquerading as Kaposi's sarcoma in East Africa. J Int Assoc Provid AIDS Care 14:21-5
Tjiam, M Christian; Taylor, James P A; Morshidi, Mazmah A et al. (2015) Viremic HIV Controllers Exhibit High Plasmacytoid Dendritic Cell-Reactive Opsonophagocytic IgG Antibody Responses against HIV-1 p24 Associated with Greater Antibody Isotype Diversification. J Immunol 194:5320-8
Huchko, Megan J; Maloba, May; Nakalembe, Miriam et al. (2015) The time has come to make cervical cancer prevention an essential part of comprehensive sexual and reproductive health services for HIV-positive women in low-income countries. J Int AIDS Soc 18:20282
Laker-Oketta, Miriam O; Wenger, Megan; Semeere, Aggrey et al. (2015) Task Shifting and Skin Punch for the Histologic Diagnosis of Kaposi's Sarcoma in Sub-Saharan Africa: A Public Health Solution to a Public Health Problem. Oncology 89:60-5

Showing the most recent 10 out of 11 publications